워싱턴의 난소암 임상 시험
난소암 관련 연구 39개가 워싱턴 내 여러 지역에서 참여자를 모집하고 있습니다.
워싱턴의 도시
공식 연구 텍스트(영어)
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
- Providence Sacred Heart Medical Center & Children's Hospital, Spokane
피험자 모집 중3상
18세 이상 · 여성 · 2026. 11. 12. 업데이트됨 · NCT06915025A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- Swedish Cancer Institute Medical Oncology, Edmonds
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06270706Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Swedish Cancer Institute-Edmonds, Edmonds
- Swedish Cancer Institute-Issaquah, Issaquah
- Providence Regional Cancer System-Lacey, Lacey
- 외 4개
피험자 모집 중2상
전 연령 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT05564377Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Providence Regional Cancer System-Aberdeen, Aberdeen
- PeaceHealth Saint Joseph Medical Center, Bellingham
- Providence Regional Cancer System-Centralia, Centralia
- 외 22개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT06580314Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
- Swedish Cancer Institute, Seattle
피험자 모집 중2상
18세 이상 · 여성 · 2026. 11. 6. 업데이트됨 · NCT06787612A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- Providence Regional Cancer System-Aberdeen, Aberdeen
- PeaceHealth Saint Joseph Medical Center, Bellingham
- Providence Regional Cancer System-Centralia, Centralia
- 외 21개
피험자 모집 중
35세 ~ 50세 · 여성 · 2026. 11. 6. 업데이트됨 · NCT04251052The Vanguard Study: Testing a New Way to Screen for Cancer
- Madigan Army Medical Center, Tacoma
피험자 모집 중건강한 지원자 환영
45세 ~ 75세 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT06995898Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study
- Fred Hutch/University of Washington Cancer Consortium, Seattle
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT06295965A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- Swedish Cancer Institute - Edmonds, Edmonds
- Swedish Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07213804Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- Swedish Cancer Institute, Everett
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05579366IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence
- Fred Hutch/University of Washington Cancer Consortium, Seattle
피험자 모집 중2상
18세 이상 · 여성 · 2026. 11. 2. 업데이트됨 · NCT07495124DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
- USA09-0, Puyallup
- USA07-0, Spokane
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 29. 업데이트됨 · NCT06953089A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Wenatchee Valley Hospital and Clinics, Wenatchee
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT06330064A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- University of Washington - Seattle Cancer Care Alliance, Seattle
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT06161025Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- Fred Hutchinson Cancer Center, Seattle
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT04981119A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Fred Hutchinson Cancer Center / University of Washington, Seattle
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 22. 업데이트됨 · NCT04657068A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
- Providence Sacred Heart Medical Center & Children'S Hospital /ID# 274585, Spokane
피험자 모집 중2상
18세 이상 · 여성 · 2026. 10. 20. 업데이트됨 · NCT06890338Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study
- University of Washington, Seattle
피험자 모집 중
18세 이상 · 여성 · 2026. 10. 15. 업데이트됨 · NCT05287451Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- Providence Sacred Heart Medical Center and Children'S Hospital, Spokane
피험자 모집 중3상
18세 이상 · 여성 · 2026. 10. 15. 업데이트됨 · NCT07214779A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
- Virginia Mason Hospital and Medical Center /ID# 277259, Seattle
피험자 모집 중2상
18세 이상 · 여성 · 2026. 10. 13. 업데이트됨 · NCT07059845Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
- Fred Hutchinson Cancer Center, Seattle
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 13. 업데이트됨 · NCT06993844The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of Washington, Fred Hutchinson Cancer Center, Seattle
피험자 모집 중1/2상
12세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT04585750A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
- Seattle Cancer Care Alliance at South Lake Union - G3630, Seattle
피험자 모집 중1/2상
18세 이상 · 여성 · 2026. 9. 24. 업데이트됨 · NCT04590326Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- University of Washington Fred Hutchinson, Seattle
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT05983432Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
- Providence Sacred Heart Medical Center & Children's Hospital, Spokane
피험자 모집 중3상
18세 이상 · 여성 · 2026. 8. 26. 업데이트됨 · NCT05281471Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
- Fred Hutchinson Cancer Center, Seattle
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 5. 업데이트됨 · NCT07444814Clinical Pre-screening Protocol for Ovarian Cancer
- Swedish Center for Research and Innovation, Seattle
피험자 모집 중관찰 연구
18세 이상 · 여성 · 2026. 7. 30. 업데이트됨 · NCT03877796A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- University of Washington School of Medicine, Seattle
피험자 모집 중2상
8세 이상 · 모든 성별 · 2026. 7. 27. 업데이트됨 · NCT05503797A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Northwest Medical Specialities. PLLC, Bonney Lake
- Swedish Cancer Institute - Edmonds Campus, Edmonds
- Swedish Cancer Institute Edmonds Campus, Edmonds
- 외 9개
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 6. 업데이트됨 · NCT04389632A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
- Fred Hutchinson Cancer Center, Seattle
- Summit Cancer Centers, Spokane
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 6. 29. 업데이트됨 · NCT05377996Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians
- Fred Hutch/University of Washington Cancer Consortium, Seattle
피험자 모집 중건강한 지원자 환영
18세 이상 · 모든 성별 · 2026. 6. 17. 업데이트됨 · NCT07282158A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- Fred Hutchinson Cancer Center, Seattle
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 6. 12. 업데이트됨 · NCT06051695ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
- Fred Hutchinson Cancer Center, Seattle
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 5. 13. 업데이트됨 · NCT03686124TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
- University of Washington, Seattle
피험자 모집 중
25세 ~ 50세 · 여성 · 2026. 4. 6. 업데이트됨 · NCT04294927Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
- Northwest Medical Specialties, PLLC, Tacoma
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 4. 1. 업데이트됨 · NCT05735080A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- Fred Hutchinson Cancer Center, Seattle
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 3. 27. 업데이트됨 · NCT06395519A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- Fred Hutchinson Cancer Center, Seattle
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 2. 13. 업데이트됨 · NCT06778863SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Seattle
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
- The Swedish Hospital, Seattle
피험자 모집 중관찰 연구
30세 이상 · 여성 · 2025. 9. 16. 업데이트됨 · NCT04794322ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.